Design Therapeutics Beheer
Beheer criteriumcontroles 2/4
Design Therapeutics' CEO is Pratik Shah, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is $6.32M, comprised of 5.7% salary and 94.3% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $675.59K. The average tenure of the management team and the board of directors is 3.2 years and 4 years respectively.
Belangrijke informatie
Pratik Shah
Algemeen directeur
US$6.3m
Totale compensatie
| Percentage CEO-salaris | 5.7% |
| Dienstverband CEO | 1.3yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 3.2yrs |
| Gemiddelde ambtstermijn bestuur | 4yrs |
Recente managementupdates
Recent updates
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Oct 04
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Jun 19Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Mar 15Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Nov 16Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation
Jun 06Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Feb 09Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Oct 25Design Therapeutics GAAP EPS of -$0.27 misses by $0.02
Aug 08We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate
Jul 02Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Mar 18Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Dec 03Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation
Aug 18Design Therapeutics expands board of directors
Jun 07Design Therapeutics EPS misses by $0.24
May 10Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$59m |
| Dec 31 2023 | US$6m | US$361k | -US$67m |
| Sep 30 2023 | n/a | n/a | -US$72m |
| Jun 30 2023 | n/a | n/a | -US$74m |
| Mar 31 2023 | n/a | n/a | -US$69m |
| Dec 31 2022 | US$5m | US$338k | -US$63m |
| Sep 30 2022 | n/a | n/a | -US$57m |
| Jun 30 2022 | n/a | n/a | -US$51m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$585k | US$310k | -US$36m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$19m |
| Mar 31 2021 | n/a | n/a | -US$13m |
| Dec 31 2020 | US$400k | US$250k | -US$8m |
Compensatie versus markt: Pratik's total compensation ($USD6.32M) is above average for companies of similar size in the US market ($USD1.48M).
Compensatie versus inkomsten: Pratik's compensation has increased whilst the company is unprofitable.
CEO
Pratik Shah (54 yo)
1.3yrs
Tenure
US$6,317,780
Compensatie
Dr. Pratik Shah, Ph D., is an Executive Chairperson at Design Therapeutics, Inc. since December 2017 and serves as its President, Chief Executive Officer and Principal Financial Officer since August 25, 20...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 1.3yrs | US$6.32m | 0.23% $ 675.6k | |
| Chief Operating Officer | 3.8yrs | US$1.28m | 1.44% $ 4.2m | |
| Co-Founder & Scientific Advisor | no data | geen gegevens | 13.54% $ 39.9m | |
| Chief Accounting Officer | 3.2yrs | geen gegevens | geen gegevens | |
| General Counsel | no data | geen gegevens | geen gegevens | |
| Consulting Chief Medical Officer | 2.8yrs | geen gegevens | 0.0084% $ 24.7k | |
| Controller | 4.6yrs | geen gegevens | geen gegevens |
3.2yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren management: DSGN's management team is considered experienced (3.2 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 6.9yrs | US$6.32m | 0.23% $ 675.6k | |
| Co-Founder & Scientific Advisor | no data | geen gegevens | 13.54% $ 39.9m | |
| Independent Director | 4yrs | US$106.70k | 0.10% $ 299.7k | |
| Independent Director | 5.3yrs | US$228.56k | 0.23% $ 691.7k | |
| Lead Independent Director | 4.8yrs | US$95.70k | 0% $ 0 | |
| Independent Director | 3.4yrs | US$94.20k | 0.042% $ 123.8k | |
| Independent Director | 3.4yrs | US$94.20k | 0.0023% $ 6.8k | |
| Independent Director | 3.8yrs | US$104.20k | 0% $ 0 |
4.0yrs
Gemiddelde duur
49yo
Gemiddelde leeftijd
Ervaren bestuur: DSGN's board of directors are considered experienced (4 years average tenure).